The hub is also expected to use lab-grown mini-organs called “organoids” and other stem cell-based systems and AI approaches, bioengineering and clinical research.
Zilbauer said the initiative could “ultimately lead to more effective, personalised therapies while reducing the time and cost of drug development”.
The hub will be led by Zilbauer and Professor Bertie Göttgens, director of the Cambridge Stem Cell Institute and co-leader of the hub.
“By bringing together hospitals, research institutes and industry partners in Cambridge and across the UK, the Hub will accelerate the development and use of new, more accurate research tools that better reflect human biology to improve the development of new therapies,” said Göttgens.
The Wellcome Sanger Institute, MRC-Laboratory of Molecular Biology (MRC-LMB) and Royal Papworth Hospital NHS Foundation Trust are also partners in the initiative.
Do you have a story suggestion for Cambridgeshire? Contact us below.